Theratechnologies (NASDAQ: THTX)
Theratechnologies Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Theratechnologies Company Info
Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which is an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montréal, Canada.
News & Analysis
No articles found.
Valuation
Earnings Transcripts
Theratechnologies Inc. (THTX) Q3 2020 Earnings Call Transcript
THTX earnings call for the period ending August 31, 2020.
Theratechnologies Inc. (THTX) Q2 2020 Earnings Call Transcript
THTX earnings call for the period ending May 31, 2020.
Theratechnologies Inc. (THTX) Q1 2020 Earnings Call Transcript
THTX earnings call for the period ending February 29, 2020.
Theratechnologies Inc. (THTX) Q4 2019 Earnings Call Transcript
THTX earnings call for the period ending November 30, 2019.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.